Abstract
Inflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) synergistically activate expression of the RANTES (regulated upon activation, normal T-cell expressed and secreted) gene, which plays a crucial role in the chemoattraction of leukocytes during the inflammatory response. To understand at the molecular level the mechanism by which the two cytokines activate RANTES gene expression, we determined the requirement of cis-acting elements in the RANTES promoter and trans-acting factors. The murine RANTES promoter contained one putative interferon regulatory factor, IRF, and three putative nuclear factor kappaB (NF-kappaB) binding sites. Specific destruction of the IRF binding site and one of the three NF-kappaB binding sites abolished the inducibility of promoter activity by IFN-gamma and TNF-alpha, respectively. In contrast, mutation of the other two putative NF-kappaB binding sites did not affect RANTES promoter activity significantly. In addition, the RANTES promoter was stimulated by co-transfection of plasmids that expressed either p65, an NF-kappaB family protein, or the IRF-1 transcription factor. RANTES promoters with mutations in the NF-kappaB or IRF binding sites were not stimulated by p65 or IRF-1 expression, respectively. In electrophoretic mobility-shift and immunologic assays, we showed that IRF-1 was induced after cells were treated with IFN-gamma and that NF-kappaB was activated by TNF-alpha treatment. These results demonstrate that both NF-kappaB and IRF-1 transcription factors mediate the induction of RANTES expression via their cognate cis-acting elements when cells are stimulated by TNF-alpha and IFN-gamma.
Full Text
The Full Text of this article is available as a PDF (239.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Becker S., Reed W., Henderson F. W., Noah T. L. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am J Physiol. 1997 Mar;272(3 Pt 1):L512–L520. doi: 10.1152/ajplung.1997.272.3.L512. [DOI] [PubMed] [Google Scholar]
- Boehm U., Klamp T., Groot M., Howard J. C. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15:749–795. doi: 10.1146/annurev.immunol.15.1.749. [DOI] [PubMed] [Google Scholar]
- Chen F. E., Ghosh G. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene. 1999 Nov 22;18(49):6845–6852. doi: 10.1038/sj.onc.1203224. [DOI] [PubMed] [Google Scholar]
- Danoff T. M., Lalley P. A., Chang Y. S., Heeger P. S., Neilson E. G. Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES. J Immunol. 1994 Feb 1;152(3):1182–1189. [PubMed] [Google Scholar]
- Devergne O., Marfaing-Koka A., Schall T. J., Leger-Ravet M. B., Sadick M., Peuchmaur M., Crevon M. C., Kim K. J., Schall T. T., Kim T. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med. 1994 May 1;179(5):1689–1694. doi: 10.1084/jem.179.5.1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drew P. D., Franzoso G., Becker K. G., Bours V., Carlson L. M., Siebenlist U., Ozato K. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J Interferon Cytokine Res. 1995 Dec;15(12):1037–1045. doi: 10.1089/jir.1995.15.1037. [DOI] [PubMed] [Google Scholar]
- Fujita T., Kimura Y., Miyamoto M., Barsoumian E. L., Taniguchi T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature. 1989 Jan 19;337(6204):270–272. doi: 10.1038/337270a0. [DOI] [PubMed] [Google Scholar]
- Fujita T., Reis L. F., Watanabe N., Kimura Y., Taniguchi T., Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9936–9940. doi: 10.1073/pnas.86.24.9936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
- Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 1989 Aug 25;58(4):729–739. doi: 10.1016/0092-8674(89)90107-4. [DOI] [PubMed] [Google Scholar]
- Heeger P., Wolf G., Meyers C., Sun M. J., O'Farrell S. C., Krensky A. M., Neilson E. G. Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. Kidney Int. 1992 Jan;41(1):220–225. doi: 10.1038/ki.1992.31. [DOI] [PubMed] [Google Scholar]
- Hornung D., Ryan I. P., Chao V. A., Vigne J. L., Schriock E. D., Taylor R. N. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab. 1997 May;82(5):1621–1628. doi: 10.1210/jcem.82.5.3919. [DOI] [PubMed] [Google Scholar]
- Kirchhoff S., Wilhelm D., Angel P., Hauser H. NFkappaB activation is required for interferon regulatory factor-1-mediated interferon beta induction. Eur J Biochem. 1999 Apr;261(2):546–554. doi: 10.1046/j.1432-1327.1999.00308.x. [DOI] [PubMed] [Google Scholar]
- Krensky A. M., Nelson P. J. Expression of chemokine RANTES and production of monoclonal antibodies. Methods Enzymol. 1997;287:162–174. doi: 10.1016/s0076-6879(97)87013-9. [DOI] [PubMed] [Google Scholar]
- Kwon O. J., Jose P. J., Robbins R. A., Schall T. J., Williams T. J., Barnes P. J. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol. 1995 May;12(5):488–496. doi: 10.1165/ajrcmb.12.5.7537968. [DOI] [PubMed] [Google Scholar]
- Lin R., Heylbroeck C., Genin P., Pitha P. M., Hiscott J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol. 1999 Feb;19(2):959–966. doi: 10.1128/mcb.19.2.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lokuta M. A., Maher J., Noe K. H., Pitha P. M., Shin M. L., Shin H. S. Mechanisms of murine RANTES chemokine gene induction by Newcastle disease virus. J Biol Chem. 1996 Jun 7;271(23):13731–13738. doi: 10.1074/jbc.271.23.13731. [DOI] [PubMed] [Google Scholar]
- Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol. 1995 Feb 15;154(4):1870–1878. [PubMed] [Google Scholar]
- Maune S., Berner I., Sticherling M., Kulke R., Bartels J., Schröder J. M. Fibroblasts but not epithelial cells obtained from human nasal mucosa produce the chemokine RANTES. Rhinology. 1996 Dec;34(4):210–214. [PubMed] [Google Scholar]
- May M. J., Ghosh S. Signal transduction through NF-kappa B. Immunol Today. 1998 Feb;19(2):80–88. doi: 10.1016/s0167-5699(97)01197-3. [DOI] [PubMed] [Google Scholar]
- Meurer R., Van Riper G., Feeney W., Cunningham P., Hora D., Jr, Springer M. S., MacIntyre D. E., Rosen H. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J Exp Med. 1993 Dec 1;178(6):1913–1921. doi: 10.1084/jem.178.6.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mori K., Stone S., Khaodhiar L., Braverman L. E., DeVito W. J. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. J Cell Biochem. 1999 Aug 1;74(2):211–219. [PubMed] [Google Scholar]
- Moriuchi H., Moriuchi M., Fauci A. S. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol. 1997 Apr 1;158(7):3483–3491. [PubMed] [Google Scholar]
- Neish A. S., Read M. A., Thanos D., Pine R., Maniatis T., Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol. 1995 May;15(5):2558–2569. doi: 10.1128/mcb.15.5.2558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson P. J., Kim H. T., Manning W. C., Goralski T. J., Krensky A. M. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol. 1993 Sep 1;151(5):2601–2612. [PubMed] [Google Scholar]
- Nelson P. J., Ortiz B. D., Pattison J. M., Krensky A. M. Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J Immunol. 1996 Aug 1;157(3):1139–1148. [PubMed] [Google Scholar]
- Nguyen H., Hiscott J., Pitha P. M. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 1997 Dec;8(4):293–312. doi: 10.1016/s1359-6101(97)00019-1. [DOI] [PubMed] [Google Scholar]
- Ortiz B. D., Krensky A. M., Nelson P. J. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol. 1996 Jan;16(1):202–210. doi: 10.1128/mcb.16.1.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pattison J. M., Nelson P. J., Huie P., Sibley R. K., Krensky A. M. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant. 1996 Dec;15(12):1194–1199. [PubMed] [Google Scholar]
- Pattison J., Nelson P. J., Huie P., von Leuttichau I., Farshid G., Sibley R. K., Krensky A. M. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet. 1994 Jan 22;343(8891):209–211. doi: 10.1016/s0140-6736(94)90992-x. [DOI] [PubMed] [Google Scholar]
- Pine R. Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element. Nucleic Acids Res. 1997 Nov 1;25(21):4346–4354. doi: 10.1093/nar/25.21.4346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Powell N., Humbert M., Durham S. R., Assoufi B., Kay A. B., Corrigan C. J. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J. 1996 Dec;9(12):2454–2460. doi: 10.1183/09031936.96.09122454. [DOI] [PubMed] [Google Scholar]
- Rathanaswami P., Hachicha M., Sadick M., Schall T. J., McColl S. R. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem. 1993 Mar 15;268(8):5834–5839. [PubMed] [Google Scholar]
- Rot A., Krieger M., Brunner T., Bischoff S. C., Schall T. J., Dahinden C. A. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med. 1992 Dec 1;176(6):1489–1495. doi: 10.1084/jem.176.6.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saito T., Deskin R. W., Casola A., Häeberle H., Olszewska B., Ernst P. B., Alam R., Ogra P. L., Garofalo R. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis. 1997 Mar;175(3):497–504. doi: 10.1093/infdis/175.3.497. [DOI] [PubMed] [Google Scholar]
- Sarkar G., Sommer S. S. The "megaprimer" method of site-directed mutagenesis. Biotechniques. 1990 Apr;8(4):404–407. [PubMed] [Google Scholar]
- Sato M., Tanaka N., Hata N., Oda E., Taniguchi T. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 1998 Mar 20;425(1):112–116. doi: 10.1016/s0014-5793(98)00210-5. [DOI] [PubMed] [Google Scholar]
- Saura M., Zaragoza C., Bao C., McMillan A., Lowenstein C. J. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol. 1999 Jun 11;289(3):459–471. doi: 10.1006/jmbi.1999.2752. [DOI] [PubMed] [Google Scholar]
- Schafer S. L., Lin R., Moore P. A., Hiscott J., Pitha P. M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem. 1998 Jan 30;273(5):2714–2720. doi: 10.1074/jbc.273.5.2714. [DOI] [PubMed] [Google Scholar]
- Schall T. J., Bacon K., Toy K. J., Goeddel D. V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990 Oct 18;347(6294):669–671. doi: 10.1038/347669a0. [DOI] [PubMed] [Google Scholar]
- Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989 Aug 11;17(15):6419–6419. doi: 10.1093/nar/17.15.6419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shin H. S., Drysdale B. E., Shin M. L., Noble P. W., Fisher S. N., Paznekas W. A. Definition of a lipopolysaccharide-responsive element in the 5'-flanking regions of MuRantes and crg-2. Mol Cell Biol. 1994 May;14(5):2914–2925. doi: 10.1128/mcb.14.5.2914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stellato C., Beck L. A., Gorgone G. A., Proud D., Schall T. J., Ono S. J., Lichtenstein L. M., Schleimer R. P. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol. 1995 Jul 1;155(1):410–418. [PubMed] [Google Scholar]
- Tanaka N., Kawakami T., Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol. 1993 Aug;13(8):4531–4538. doi: 10.1128/mcb.13.8.4531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolf G., Aberle S., Thaiss F., Nelson P. J., Krensky A. M., Neilson E. G., Stahl R. A. TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int. 1993 Oct;44(4):795–804. doi: 10.1038/ki.1993.314. [DOI] [PubMed] [Google Scholar]